Shahna Shahulhameed

Shahna Shahulhameed

Auto-generated profile, based on publicly available information

Shahna Shahulhameed

Department of Ophthalmology Indiana University School of Medicine Indianapolis Indiana

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SSShahna Shahulhameed
Shahna Shahulhameed
SVSushma Vishwakarma
Sushma Vishwakarma
Jay ChhablaniJay Chhablani
Jay Chhablani
MTMudit Tyagi
Mudit Tyagi
RPRajeev R. Pappuru
Rajeev R. Pappuru
IKInderjeet Kaut
Inderjeet Kaut
The complement system plays a crucial role in retinal homeostasis. While the proteomic analysis of ocular tissues in diabetic retinopathy (DR) has shown the deposition of complement proteins, their exact role in the pathogenesis of DR is yet unclear. We performed a detailed investigation of the role of the complement system by evaluating the levels of major complement proteins including C3, C1q, C4b, Complement Factor B (CFB), and Complement Factor H (CFH) and their activated fragments from both the classical and alternative pathways in vitreous humor and serum samples from proliferative DR (PDR) patients and controls. Further, the expressions of complements and several other key pro- and anti-angiogenic genes in the serum and vitreous humor were analyzed in the blood samples of PDR and non-PDR (NPDR) patients along with controls without diabetes. We also assessed the pro-inflammatory cytokines and matrix metalloproteinases in the vitreous humor samples. There was a significant increase in C3 and its activated fragment C3bα' (110 kDa) along with a corresponding upregulation of CFH in the vitreous of PDR patients, which confirmed the increased activation of the alternative complement pathway in PDR. Likewise, a significant upregulation of angiogenic genes and downregulation of anti-angiogenic genes was seen in PDR and NPDR cases. Increased MMP9 activity and upregulation of inflammatory markers IL8 and sPECAM with a downregulation of anti-inflammatory marker IL-10 in PDR vitreous indicated the possible involvement of microglia in DR pathogenesis. Further, a significantly high C3 deposition in the capillary wall along with thickening of basement membranes and co-localization of CFH expression with CD11b+ve activated microglial cells in diabetic retina suggested microglia as a source of CFH in diabetic retina. The increased CFH levels could be a feedback mechanism for arresting excessive complement activation in DR eyes. A gradual increase of CFH and CD11b expression in retina with early to late changes in epiretinal membranes of DR patients indicated a major role for the alternative complement pathway in disease progression.

22 December 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
SRSonika Rathi
Sonika Rathi
SJSubhadra Jalali
Subhadra Jalali
SPSatish Patnaik
Satish Patnaik
SSShahna Shahulhameed
Shahna Shahulhameed
GMGaneswara R. Musada
Ganeswara R. Musada
IKInderjeet Kaut
Inderjeet Kaut
Retinopathy of prematurity (ROP) is a neurovascular complication in preterm babies, leading to severe visual impairment, but the underlying mechanisms are yet unclear. The present study aimed at unraveling the molecular mechanisms underlying the pathogenesis of ROP. A comprehensive screening of candidate genes in preterms with ROP (n = 189) and no-ROP (n = 167) was undertaken to identify variants conferring disease susceptibility. Allele and genotype frequencies, linkage disequilibrium and haplotypes were analyzed to identify the ROP-associated variants. Variants in CFH (p = 2.94 × 10−7), CFB (p = 1.71 × 10−5), FBLN5 (p = 9.2 × 10−4), CETP (p = 2.99 × 10−5), and CXCR4 (p = 1.32 × 10−8) genes exhibited significant associations with ROP. Further, a quantitative assessment of 27 candidate proteins and cytokines in the vitreous and tear samples of babies with severe ROP (n = 30) and congenital cataract (n = 30) was undertaken by multiplex bead arrays and further validated by western blotting and zymography. Significant elevation and activation of MMP9 (p = 0.038), CFH (p = 2.24 × 10−5), C3 (p = 0.05), C4 (p = 0.001), IL-1ra (p = 0.0019), vascular endothelial growth factor (VEGF) (p = 0.0027), and G-CSF (p = 0.0099) proteins were observed in the vitreous of ROP babies suggesting an increased inflammation under hypoxic condition. Along with inflammatory markers, activated macrophage/microglia were also detected in the vitreous of ROP babies that secreted complement component C3, VEGF, IL-1ra, and MMP-9 under hypoxic stress in a cell culture model. Increased expression of the inflammatory markers like the IL-1ra (p = 0.014), MMP2 (p = 0.0085), and MMP-9 (p = 0.03) in the tears of babies at different stages of ROP further demonstrated their potential role in disease progression. Based on these findings, we conclude that increased complement activation in the retina/vitreous in turn activated microglia leading to increased inflammation. A quantitative assessment of inflammatory markers in tears could help in early prediction of ROP progression and facilitate effective management of the disease, thereby preventing visual impairment.

7 February 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
SSShahna Shahulhameed
Shahna Shahulhameed
SSSarpras Swain
Sarpras Swain
SJSoumya Jana
Soumya Jana
Jay ChhablaniJay Chhablani
Jay Chhablani
MAMohammad Javed Ali
Mohammad Javed Ali
IKInderjeet Kaut
Inderjeet Kaut
The detailed mechanisms underlying oxidative stress that leads to neuroinflammation and neurodegeneration in retinal vascular conditions, including diabetic retinopathy, retinopathy of prematurity etc., remain largely unexplored mainly due to a lack of suitable disease models that can simulate the inherent neuron–glia interactions in human retina. Specifically, establishment of a mixed retinal culture (MRC) containing both neuron and glial cell types remains a challenge due to different conditions required for their optimal growth and differentiation. Here, we establish a novel primary MRC model system containing neurons, astrocytes, Müller glia, and microglia from human donor retina that can be used to study the neuromodulatory effects of glial cells under the stress. The cell characterization based on immunostaining with individual cell type–specific markers and their presence in close vicinity to each other further underscores their utility for studying their cross talk. To the best of our knowledge, this is the first instance of an in vitro model obtained from human donor retina containing four major cell types. Next, we induce hypoxic stress to MRC to investigate if hypoxia activated neuroglia modulates altered gene expression for inflammatory, apoptotic, and angiogenic markers and Ca2+ transients by live cell imaging. Further, we performed k-means clustering of the Ca2+ responses to identify the modification of clustering pattern in stressed condition. Finally, we provide the evidence that the altered Ca2+ transient correlates to differential expression of genes shown to be involved in neuroinflammation, angiogenesis, and neurodegeneration under the hypoxic conditions as seen earlier in human cell lines and animal models of diabetic retinopathy. The major features of the hypoxic conditions in the proposed human MRC model included: increase in microglia activity, chemokine and cytokine expression, and percentage of cells having higher amplitude and frequency of Ca2+ transients. Thus, the proposed experimental system can potentially serve as an ideal in vitro model for studying the neuroinflammatory and neurodegenerative changes in the retina and identifying newer drug targets.

9 January 2025 in Current Protocols
Verified
Journal Article
Open access
SHShahna S. Hameed
Shahna S. Hameed
TSTasneem Putliwala Sharma
Tasneem Putliwala Sharma
Human induced pluripotent stem cell (hiPSC)‐based disease modeling can be successfully recapitulated to mimic disease characteristics across various human pathologies. Glaucoma, a progressive optic neuropathy, primarily affects the retinal ganglion cells (RGCs). While multiple groups have successfully generated RGCs from non‐diseased hiPSCs, producing RGCs from glaucomatous human samples holds significant promise for understanding disease pathology by revealing patient‐specific disease signatures. Given that keratocytes originate from the neural crest and previous reports suggest that ocular fibroblasts from glaucomatous donors carry pathogenic signatures, it is highly plausible that these signatures imprinted within the keratocytes will also be present in the derived RGCs. Thus, we aimed to generate RGCs from both glaucomatous and non‐glaucomatous donor keratocytes and validate disease‐specific signatures in 3D retinal organoids and in isolated RGCs. Our protocol describes the generation of iPSCs from keratocytes of both glaucomatous and non‐glaucomatous donors, followed by their differentiation into retinal organoids. Subsequent isolation and culturing of RGCs were performed. Disease signatures in the RGCs were validated in both 3D retinal organoids (ROs) and 2D RGC cultures, and glaucomatous RGCs in 3D and 2D cultures demonstrated increased cleaved CASP3 and significant RGC loss, indicating disease imprints in the hiPSC‐derived RGCs. This model offers a venue and high throughput platform for studying glaucomatous disease pathology and holds significant potential for drug discovery using RGCs derived from human donors. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Culturing of keratocytes from human cadaveric donorsBasic Protocol 2: Reprogramming donor keratocytes into iPSCsBasic Protocol 3: Evaluation of chromosomal loss during reprogramming in iPSCs by karyotypingBasic Protocol 4: Generation of 3D ROsBasic Protocol 5: Dissociation and culturing of RGCs from 3D ROsSupport Protocol 1: Immunostaining for phenotypic characterization of cellsSupport Protocol 2: Sectioning of 3D ROs and immunostainingSupport Protocol 3: Western blotting for cleaved CASP3 and THY1

1 July 2019
Verified
Conference Paper
Closed access
DSDivya Spoorthy
Divya Spoorthy
SMShanmukh Reddy Manne
Shanmukh Reddy Manne
VDVaibhav Dhyani
Vaibhav Dhyani
SSSarpras Swain
Sarpras Swain
SSShahna Shahulhameed
Shahna Shahulhameed
SJSoumya Jana
Soumya Jana
Despite providing high spatial resolution, functional imaging remains largely unsuitable for high-throughput experiments because current practices require cells to be manually identified in a time-consuming procedure. Against this backdrop, we seek to integrate such high-resolution technique in high-throughput workflow by automating the process of cell identification. As a step forward, we attempt to identify mixed retinal cells in time-lapse fluorescent microscopy images. Unfortunately, usual 2D image segmentation as well as other existing methods do not adequately distinguish between time courses of different spatial locations. Here, the task gets further complicated due to the inherent heterogeneity of cell morphology. To overcome such challenge, we propose to use a high-dimensional (HiD) version of DBSCAN (density based spatial clustering of applications with noise) algorithm, where difference in such time courses are appropriately accounted. Significantly, outcome of the proposed method matches manually identified cells with over 80% accuracy, marking more than 50% improvement compared to a reference 2D method.

31 December 2022 in Proceedings of IMPRS
Verified
Journal Article
Open access
PDF file
Kathleen Kuo HoKathleen Kuo Ho
Kathleen Kuo Ho
SHShahna Shahul Hameed
Shahna Shahul Hameed
TSTasneem Putliwala Sharma
Tasneem Putliwala Sharma
Purpose: Glaucoma is a group of optic neuropathies characterized by retinal ganglion cell (RGC) death and visual field loss. A degenerative mechanism associated with RGC death is disrupted delivery of neurotropic factors due to glaucomatous axonal damage. This transport is critical for protection of long-term neuronal function. Thus, we investigate a potential therapeutic target, human Neuritin 1 (NRN1), which has demonstrated neuroprotective effects in rodent axonal injury models. Further, the advent of induced pluripotent stem cell (iPSC) technology allows iPSC-RGCs to be generated in-vitro from commercial iPSCs and reprogrammed corneal fibroblasts. We hypothesize delivery of NRN1 and transplantation of iPSC-RGCs will sustain survival of RGCs and ultimately slow progression of glaucoma-induced neuronal death in our ocular translaminar autonomous system (TAS) perfusion model system. This will allow us to analyze a potential therapeutic approach for both early-stage glaucoma (NRN1 therapy) to protect dying RGCs, and late-stage (iPSC-RGCs), when most RGCs are lost. Methods: Human donor eyes were obtained from eye banks according to Declaration of Helsinki. The iPSC-RGCs transfected with AAV2-GFP were seeded into human posterior cups with NRN1 and cultured in TAS model under pressurized conditions for 2 days. Survival of iPSC-RGCs, gliotic and fibrotic pathways were measured through expression by qRT-PCR and immunohistochemistry. Retinal function post-treatment was measured through electroretinogram analysis. Results: We successfully maintained the human posterior eye cups in translaminar differentials for 2 days. In contrast to controls, we observed increased RGC survival and retinal function after combination therapy of NRN1 and iPSC-RGC. Additionally, we found differential gene expression of apoptosis, inflammation, and gliotic markers. Conclusion: Our study identified that NRN1 in conjunction with iPSC-RGC transplantation treatment promotes RGC survival under glaucomatous conditions. This suggests that NRN1 and iPSC-RGCs could be utilized as a potential combination therapy to save retinal neurons and prevent neurodegeneration in glaucoma patients.